Polish research team to carry out an international research project on antibiotic resistance with nearly 1 million PLN awarded for that purpose.
A research team managed by Prof. Dr Hab. Zuzanna Drulis-Kawa from the University of Wrocław was awarded in the 14th JPIAMR call: Disrupting drug Resistance Using Innovative Design (DRUID). Polish researchers will coordinate research tasks in collaboration with research teams from Belgium, France, Germany and Israel. In the project: Design and implementation of effective cOmbination of Phages and Antibiotics for improved TheRApy protocols against KLEbsiella pneumoniae, they will develop a method for treating patients infected with Klebsiella pneumoniae (considered a new priority pathogen, WHO priority 1).
The KLEOPATRA consortium will apply a ‘One Health’ approach to support research on antimicrobial therapy by way of improving the efficiency, distinctiveness and methods of delivering, combining or repurposing drugs or pesticides to treat bacterial or fungal infections. As part of the project, research teams will analyse the most common strains of K. pneumoniae in human and animal reservoirs and environmental ecosystems.
14th JPIAMR call
Thirteen projects involving 72 partners from 15 countries were recommended for funding in the 14th international JPIAMR call: Disrupting drug Resistance Using Innovative Design (DRUID). The total amount of 15.4 mln EUR will be awarded for that purpose.
For more details on the call, please visit the website of JPIAMR
Polish project description: KLEOPATRA